Marcus A. Conant

716 total citations
11 papers, 499 citations indexed

About

Marcus A. Conant is a scholar working on Epidemiology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Marcus A. Conant has authored 11 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 3 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Marcus A. Conant's work include Herpesvirus Infections and Treatments (4 papers), Viral-associated cancers and disorders (3 papers) and Drug-Induced Adverse Reactions (3 papers). Marcus A. Conant is often cited by papers focused on Herpesvirus Infections and Treatments (4 papers), Viral-associated cancers and disorders (3 papers) and Drug-Induced Adverse Reactions (3 papers). Marcus A. Conant collaborates with scholars based in United States, United Kingdom and Canada. Marcus A. Conant's co-authors include Timothy G. Berger, Steven F. Wolfe, Jordan W. Tappero, Don Ganem, Edward Katongole‐Mbidde, Steven L. Chuck, Robert M. Grant, David M. Meisler, Bartly J. Mondino and Gary N. Holland and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of the American Academy of Dermatology and AIDS.

In The Last Decade

Marcus A. Conant

11 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus A. Conant United States 8 264 260 114 113 110 11 499
Malin Enbom Sweden 12 310 1.2× 318 1.2× 187 1.6× 32 0.3× 110 1.0× 18 487
R. Bartralot Spain 13 63 0.2× 306 1.2× 112 1.0× 39 0.3× 66 0.6× 27 471
Greenspan Js United States 13 100 0.4× 113 0.4× 79 0.7× 43 0.4× 48 0.4× 25 494
Anthony Yung United States 12 110 0.4× 159 0.6× 146 1.3× 53 0.5× 95 0.9× 42 596
Louise E. Kimball United States 12 343 1.3× 629 2.4× 203 1.8× 28 0.2× 44 0.4× 27 820
J.-M. Huraux France 11 649 2.5× 585 2.3× 274 2.4× 130 1.2× 112 1.0× 26 873
J. W. Mugerwa Uganda 9 277 1.0× 190 0.7× 142 1.2× 103 0.9× 118 1.1× 11 503
E Vasak Australia 11 162 0.6× 202 0.8× 230 2.0× 40 0.4× 102 0.9× 14 574
Daniel Carrasco United States 12 37 0.1× 170 0.7× 45 0.4× 52 0.5× 37 0.3× 27 331
W Henle United States 9 396 1.5× 389 1.5× 219 1.9× 38 0.3× 115 1.0× 11 717

Countries citing papers authored by Marcus A. Conant

Since Specialization
Citations

This map shows the geographic impact of Marcus A. Conant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus A. Conant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus A. Conant more than expected).

Fields of papers citing papers by Marcus A. Conant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus A. Conant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus A. Conant. The network helps show where Marcus A. Conant may publish in the future.

Co-authorship network of co-authors of Marcus A. Conant

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus A. Conant. A scholar is included among the top collaborators of Marcus A. Conant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus A. Conant. Marcus A. Conant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gilson, Richard, Jerome L. Shupack, Alvin E. Friedman‐Kien, et al.. (1999). A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. AIDS. 13(17). 2397–2404. 65 indexed citations
2.
Conant, Marcus A.. (1996). FUNGAL INFECTIONS IN IMMUNOCOMPROMISED INDIVIDUALS. Dermatologic Clinics. 14(1). 155–162. 12 indexed citations
3.
Chuck, Steven L., Robert M. Grant, Edward Katongole‐Mbidde, Marcus A. Conant, & Don Ganem. (1996). Frequent Presence of a Novel Herpesvirus Genome in Lesions of Human Immunodeficiency Virus-Negative Kaposi's Sarcoma. The Journal of Infectious Diseases. 173(1). 248–251. 68 indexed citations
4.
Conant, Marcus A.. (1995). New treatment options for onychomycosis.. PubMed. 9 Suppl 1. S19–21. 2 indexed citations
5.
Tappero, Jordan W., Marcus A. Conant, Steven F. Wolfe, & Timothy G. Berger. (1993). Kaposi's sarcoma. Journal of the American Academy of Dermatology. 28(3). 371–395. 202 indexed citations
6.
Lebwohl, Mark, Stephen L. Sacks, Marcus A. Conant, et al.. (1992). Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis. Antiviral Research. 17(3). 235–243. 15 indexed citations
7.
Conant, Marcus A., et al.. (1989). Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. Journal of the American Academy of Dermatology. 20(4). 637–642. 51 indexed citations
8.
Meisler, David M., et al.. (1984). Herpes Zoster Ophthalmicus and Acquired Immune Deficiency Syndrome. Archives of Ophthalmology. 102(7). 1027–1029. 62 indexed citations
9.
Silverman, S, et al.. (1983). Current assessment; dental risks and guidelines in the AIDS epidemic.. PubMed. 11(10). 7–10. 2 indexed citations
10.
Okumoto, Masao, et al.. (1983). Drug‐induced cicatrisation of the conjunctiva. Contact Dermatitis. 9(2). 155–155. 4 indexed citations
11.
Ostler, H. Bruce, et al.. (1971). Lyell's disease, the Stevens-Johnson Syndrome, and exfoliative dermatitis.. PubMed. 74(6). 1254–65. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026